Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
We show a GREB1-ER interaction in three xenograft tumors, and using a directed protein-protein approach, we find GREB1-ER interactions in half of ER(+) primary breast cancers.
|
23403292 |
2013 |
Neoplasm Metastasis
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We report a novel translocation t(2;3)(p25;p22) involving the GREB1 (intron 8) and CTNNB1 (exon 3) in a uterine tumor resembling ovarian sex cord tumor (UTROSCT), which exhibited extrauterine metastasis.
|
30350331 |
2019 |
Uterine tumor resembling ovarian sex cord tumor
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We report a novel translocation t(2;3)(p25;p22) involving the GREB1 (intron 8) and CTNNB1 (exon 3) in a uterine tumor resembling ovarian sex cord tumor (UTROSCT), which exhibited extrauterine metastasis.
|
30350331 |
2019 |
Hepatoblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We propose that GREB1 is a target molecule of Wnt/β-catenin signaling and required for HB progression.
|
31462641 |
2019 |
Endometrial Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We also found that GREB1-deficient Ishikawa cells are much more resistant to chemotherapy and that human endometrial cancers with low GREB1 expression predict poor disease-free survival.
|
31744881 |
2019 |
Uterine Fibroids
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits.
|
30194396 |
2018 |
Plexiform leiomyoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits.
|
30194396 |
2018 |
Developmental delay (disorder)
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
To investigate its function, we utilized TALEN-mediated knockout strategy and obtained a greb1 mutant zebrafish line. greb1 mutation caused convergent extension (CE) movement defect and developmental delay during gastrulation, and resulted in significant growth defects in zebrafish adults.
|
28606834 |
2017 |
Global developmental delay
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To investigate its function, we utilized TALEN-mediated knockout strategy and obtained a greb1 mutant zebrafish line. greb1 mutation caused convergent extension (CE) movement defect and developmental delay during gastrulation, and resulted in significant growth defects in zebrafish adults.
|
28606834 |
2017 |
Endometriosis
|
0.460 |
Biomarker
|
disease |
BEFREE |
To analyze the expression of estrogen receptors α and β as well as their target genes implicated in proliferation, c-myc, cyclin D1, and GREB1, in the endometrium of women with or without endometriosis.
|
22884659 |
2012 |
Malignant neoplasm of prostate
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
Tissue expression of GREB1 is associated with organ-confined prostate cancer and may constitute a gene associated with a favorable prognosis.
|
19945309 |
2012 |
Prostate carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Tissue expression of GREB1 is associated with organ-confined prostate cancer and may constitute a gene associated with a favorable prognosis.
|
19945309 |
2012 |
Malignant neoplasm of breast
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.
|
22359603 |
2012 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.
|
22359603 |
2012 |
Malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
The logistic regression model combining five of the mRNA biomarkers (CCNI, EGFR, FGF19, FRS2, and GREB1) could differentiate lung cancer patients from normal control subjects, yielding AUC value of 0.925 with 93.75 % sensitivity and 82.81 % specificity in the pre-validation sample set.
|
22689099 |
2012 |
Carcinoma of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
The logistic regression model combining five of the mRNA biomarkers (CCNI, EGFR, FGF19, FRS2, and GREB1) could differentiate lung cancer patients from normal control subjects, yielding AUC value of 0.925 with 93.75 % sensitivity and 82.81 % specificity in the pre-validation sample set.
|
22689099 |
2012 |
Primary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
The logistic regression model combining five of the mRNA biomarkers (CCNI, EGFR, FGF19, FRS2, and GREB1) could differentiate lung cancer patients from normal control subjects, yielding AUC value of 0.925 with 93.75 % sensitivity and 82.81 % specificity in the pre-validation sample set.
|
22689099 |
2012 |
Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
The expression of gene regulated by estrogen in breast cancer 1 (Greb1) was upregulated in mouse tumors treated with E2 and was overexpressed in human ovarian cancers relative to human ovarian surface epithelium, suggesting a role for GREB1 in human ovarian tumor progression.
|
24469735 |
2014 |
Endometriosis
|
0.460 |
AlteredExpression
|
disease |
BEFREE |
The differential expression of GREB1 has also been reported by others in association with endometriosis disease phenotype.
|
25788566 |
2015 |
Carcinogenesis
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
The CTNNB1 gene fusion, promoted by an estrogen-responsive gene (GREB1), could be a potential driver of tumorigenesis in this case and a therapeutic target with adapted inhibitors.
|
30350331 |
2019 |
Malignant neoplasm of breast
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Studies in primary breast cancers showed that PDZK1 and GREB1 were overexpressed in ER-positive breast cancers as compared with ER-negative breast cancers by 19-fold and 3.5-fold, respectively.
|
11103799 |
2000 |
Mammary Neoplasms
|
0.020 |
Biomarker
|
group |
LHGDN |
Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences.
|
17463000 |
2007 |
Hormone refractory prostate cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Real-time PCR demonstrated high level GREB1 expression in benign prostatic hypertrophy (BPH), localized prostate cancer (L-PCa), and hormone refractory prostate cancer (HR-PCa).
|
16496412 |
2006 |
Polycystic Ovary Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
RAD54B and GREB1 gene polymorphisms may not be associated with PCOS in the Han Chinese population.
|
23876972 |
2013 |
Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
PDZK1 and a new gene, GREB1, demonstrated a significant correlation with ER phenotype in a panel of breast cancer cell lines.
|
11103799 |
2000 |